Health Sciences Assistant Clinical Professor, Internal Medicine, UCSF School of Medicine
Internal Medicine
Dr. Heather D. Harris, DO
|
|
Give Review
Heather Harris is an expert in the field of Internal Medicine. She went to Stanford University School of Medicine. Stanford University School of Medicine is a top medical college. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine Heather Harris is a published doctor. She has 56 publications published. The most current publication "Is curettage needed for uncomplicated incomplete spontaneous abortion?" Heather Harris accepts all Medicare patients.
Publications
- Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis (Br J Surg 2012; 99: 761-766).
- A mouse model of androgenetic alopecia.
- Estrogen receptor beta agonism increases survival in experimentally induced sepsis and ameliorates the genomic sepsis signature: a pharmacogenomic study.
- Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.
- Estrogen receptor beta-selective agonists stimulate calcium oscillations in human and mouse embryonic stem cell-derived neurons.
- Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.
- Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.
- Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists.
- Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes.
- Estrogen receptor-beta: recent lessons from in vivo studies.
- WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock.
- Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: responses to disease induction and therapy with the estrogen rece...
- The unexpected science of estrogen receptor-beta selective agonists: a new class of anti-inflammatory agents?
- Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity.
- ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity.
- Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity.
- Structure-based design of estrogen receptor-beta selective ligands.
- Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
- Determination of rat oral bioavailability of soy-derived phytoestrogens using an automated on-column extraction procedure and electrospray tandem mass spectrometry.
- Evaluation of an estrogen receptor-beta agonist in animal models of human disease.
- Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
- Global transcription profiling of estrogen activity: estrogen receptor alpha regulates gene expression in the kidney.
- Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand.
- Estrogen receptors alpha and beta have similar activities in multiple endothelial cell pathways.
- Estrogenic effects of 7alpha-methyl-17alpha-ethynylestradiol: a newly discovered tibolone metabolite.
- The ligand binding profiles of estrogen receptors alpha and beta are species dependent.
- Is curettage needed for uncomplicated incomplete spontaneous abortion?
- Progress and prospects in treating postmenopausal vaginal atrophy.
- Expression of meltrin-alpha mRNA is not restricted to fusagenic cells.
- Preclinical characterization of selective estrogen receptor beta agonists: new insights into their therapeutic potential.
- Synthesis and estrogenic activities of novel 7-thiosubstituted estratriene derivatives.
- Functional properties of a conditionally phenotypic, estrogen-responsive, human osteoblast cell line.
- Design, synthesis, and preclinical characterization of novel, highly selective indole estrogens.
- Regulation of metallothionein II messenger ribonucleic acid measures exogenous estrogen receptor-beta activity in SAOS-2 and LNCaPLN3 cells.
- Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts.
- ERbeta ligands. Part 1: the discovery of ERbeta selective ligands which embrace the 4-hydroxy-biphenyl template.
- Constrained phytoestrogens and analogues as ERbeta selective ligands.
- 7-Substituted 2-phenyl-benzofurans as ER beta selective ligands.
- ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives.
- Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol.
- ERbeta ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor beta-selective ligands.
- ERbeta ligands. Part 5: synthesis and structure-activity relationships of a series of 4''-hydroxyphenyl-aryl-carbaldehyde oxime derivatives.
- An estrogen receptor-beta agonist is active in models of inflammatory and chemical-induced pain.
- Estrogen receptor beta ligands: design and synthesis of new 2-phenyl-isoindole-1,3-diones.
- Development of a mouse model of mammary gland versus uterus tissue selectivity using estrogen- and progesterone-regulated gene markers.
- A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis.
- Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones.
- Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands.
- Development of an early biomarker for the ovarian liability of selective estrogen receptor modulators in rats.
- Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal woman.
- Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
- Trace LC/MS/MS quantitation of 17beta-estradiol as a biomarker for selective estrogen receptor modulator activity in the rat brain.
- Modulation of responses to stress by estradiol benzoate and selective estrogen receptor agonists.
- A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy.
- ERbeta ligands. Part 4: Synthesis and structure-activity relationships of a series of 2-phenylquinoline derivatives.
Schools
Stanford University
University of Osteopathic Medicine And Health Sciences College of Osteopathic Medicine
Doctors Specialties
- Palliative Medicine
- Internal Medicine
Accepted Insurances
Education
-
UCSF -
Stanford University School of Medicine
Hospital
-
El Camino Hospital -
Stanford Health Care -
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Gordon Lang, MD |
|
|
Dr. Steven D. Rankin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kayla Gray, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randy A. Cook, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Olivia A. Fondoble, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pravin Pratap, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Georgios Psarros, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard S. Rigmaiden III, MD
This Doctor is OpenDoctor Recommended.
|